Results 241 to 250 of about 950,400 (402)

Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Machine‐learning (ML) models in flow cytometry have the potential to reduce error rates, increase reproducibility, and boost the efficiency of clinical labs. While numerous ML models for flow cytometry data have been proposed, few studies have described the clinical deployment of such models.
Lauren M. Zuromski   +10 more
wiley   +1 more source

Chronic Myeloid Leukemia in a Young Adult. [PDF]

open access: yesCureus
Patel K   +4 more
europepmc   +1 more source

Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region [published erratum appears in Blood 1988 Jan;71(1):272] [PDF]

open access: bronze, 1987
Licia Selleri   +8 more
openalex   +1 more source

Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5‐year survival rate of only 20–30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single‐center cohort using a novel quantitative computational pipeline.
Artuur Couckuyt   +10 more
wiley   +1 more source

DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes [PDF]

open access: bronze, 1986
Wolfgang Hiddemann   +3 more
openalex   +1 more source

A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract T‐lineage acute lymphoblastic leukemia (T‐ALL) is an aggressive neoplasm of immature T cells. Flow cytometry plays a critical role in the diagnosis and management of the disease. It is used to establish the abnormal immature T‐cell phenotype and to distinguish the early T‐cell precursor (ETP)‐ALL from more mature types at diagnosis.
Qi Gao   +8 more
wiley   +1 more source

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia. [PDF]

open access: yesDiscov Oncol
Abdalla AZ   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy